Section Arrow
NKTR.NASDAQ
- Nektar Therapeutics
Quotes are at least 15-min delayed:2026/01/09 09:58 EST
Regular Hours
Last
 41.01
-0.43 (-1.04%)
Day High 
41.89 
Prev. Close
41.44 
1-M High
59.23 
Volume 
50.34K 
Bid
41.01
Ask
41.2
Day Low
41.01 
Open
41.2 
1-M Low
41.25 
Market Cap 
842.96M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 43.12 
20-SMA 46.07 
50-SMA 53.57 
52-W High 66.92 
52-W Low 6.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-9.83/-11.22
Enterprise Value
925.65M
Balance Sheet
Book Value Per Share
4.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
217.72M
Operating Revenue Per Share
4.34
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBIOiBio2.615+0.265+11.28%0.65PE
SLSSELLAS Life Sciences Group3.3355-0.5245-13.59%-- 
ASBPAspire Biopharma Holdings Inc.0.0992-0.0041-3.97%-- 
ARDXArdelyx7.66+0.66+9.43%-- 
MREOMereo BioPharma Group plc0.4119+0.0275+7.15%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.